PROTAGONIST THERAPEUTICS INC's ticker is and the CUSIP is 38141G107. A total of 1 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,052,325 | -39.6% | 63,089 | -0.1% | 0.78% | -37.3% |
| Q2 2023 | $1,743,402 | +20.1% | 63,121 | 0.0% | 1.24% | +14.2% |
| Q1 2023 | $1,451,783 | +110.8% | 63,121 | 0.0% | 1.08% | +104.0% |
| Q4 2022 | $688,650 | -37.6% | 63,121 | -51.8% | 0.53% | -40.3% |
| Q3 2022 | $1,103,000 | -16.7% | 130,881 | -18.0% | 0.89% | -7.3% |
| Q2 2022 | $1,324,000 | – | 159,592 | – | 0.96% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Twin Lakes Capital Management, LLC | 63,121 | $1,451,783 | 1.08% |